Symposiums

Prof Gerd Horneff opened the symposium with a summary of the recent advances in the understanding of the role of interleukin (IL)-1β in the pathogenesis…

Lysosomal acid lipase deficiency (LAL-D), historically known as Wolman’s disease or cholesteryl ester storage disease, is a severe, underdiagnosed, and…

In light of recent economic challenges, reductions in healthcare spending are vital to sustain the level of care in health services across the world.

Prof Tekgül opened this symposium on nocturnal enuresis (NE). Prof Bogaert described new digital initiatives for engaging with children, parents, and…

Despite major advances in the inflammatory bowel disease (IBD) treatment landscape, the management of ulcerative colitis (UC) and Crohn’s disease (CD)…

This symposium provided an opportunity for global experts to discuss the challenges posed by the introduction of biosimilars. The impact of the…

Ulcerative colitis (UC) carries a significant, progressive disease burden that is often underestimated or misinterpreted by healthcare providers.

The importance of the gut microbiota to health is becoming more widely appreciated. The range of commensal microorganisms in healthy individuals and in…